Latest in FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Sort by
1,578 items
-
OpenAI says DeepSeek may have 'inapproriately' used its data
OpenAI itself has been accused of building ChatGPT by inappropriately accessing content it didn't have the rights to.NBC News - 18h -
RFK Jr. on chronic disease research
Sen. Maria Cantwell (D-WA) asked Robert F. Kennedy Jr. about National Institutes of Health research and innovation and expressed her concern on chronic disease emphasis, not infectious disease. RFK ...CBS News - 1d -
OpenAI says Chinese rivals using its work for their AI apps
ChatGPT maker says it will need extra protection from US government, following emergence of Chinese rival, DeepSeek.BBC News - 1d -
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.CNBC - 1d -
An Indian Jewelry Brand Expands Its World
Bhagat, the celebrated jeweler, opens a boutique in London — its first outside of its home country.The New York Times - 4d -
Novo Nordisk shares pop on early-stage weight loss drug trial results
The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.CNBC - 6d -
Novo Nordisk Shares Surge on New Obesity Drug Results
Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.The Wall Street Journal - 6d -
Ozempic maker’s stock surges. A trial of a new Novo Nordisk drug shows promise.
Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much as 22%.MarketWatch - 6d -
Mexico’s Ambitious Plan to Prepare to Receive Its Citizens Deported From the US
The plan, called “Mexico Embraces You,” seeks to reassure undocumented migrants facing expulsion. Some experts question if the government is really ready to reabsorb them.The New York Times - 6d -
Trump's bid to expand presidential power hits its first snag: From the Politics Desk
Welcome to the online version of From the Politics Desk, an evening newsletter that brings you the NBC News Politics team’s latest reporting and analysis from the White House, Capitol Hill and the ...NBC News - 6d -
Trump says he will use energy emergency declaration to approve more power for AI
President Trump said Thursday that he will use his energy emergency declaration to approve power stations for artificial intelligence (AI) centers. Speaking at the World Economic Forum, Trump said: ...The Hill - 6d -
Under Trump, US Cyberdefense Loses Its Head
Chinese hacks, rampant ransomware, and Donald Trump’s budget cuts all threaten US security. In an exit interview with WIRED, former CISA head Jen Easterly argues for her agency’s survival.Wired - Jan. 23 -
Trump order leaves Afghans who were approved to resettle in the US in limbo
Trump's executive order freezing refugee programs could impact thousands of Afghans approved to resettle as refugees in the US.ABC News - Jan. 22 -
Trump administration cancels travel for refugees approved to resettle in US
Thousands of refugees now stranded around the globe after undergoing lengthy process to be permitted to come to US. US politics live – latest updates Trump to deploy troops to US-Mexico border ...The Guardian - Jan. 22 -
Nose spray to treat depression? FDA approves first-of-its-kind medicine
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.The Hill - Jan. 22 -
FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment
Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.CNBC - Jan. 21 -
Ørsted announces further writedown on its US offshore wind business
Danish developer blames interest rates, supply chains and ‘market uncertainties’ for the latest impairmentFinancial Times - Jan. 20 -
Toast, the Low-Key Brand, Expands Its U.S. Presence
A low-key brand, founded by archaeologists in Wales, has quietly expanded in New York.The New York Times - Jan. 20 -
Ozempic picked for Medicare price bargaining
Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Biden adds Ozempic to list for Medicare price negotiation In one of its last actions, the Biden administration ...The Hill - Jan. 17 -
Obesity drugs Ozempic and Wegovy included in US price-cut talks
Novo Nordisk shares hit as government adds blockbuster weight-loss treatments to new round of negotiationsFinancial Times - Jan. 17 -
Starbucks Reverses Its Open-Door Policy for Bathroom Use and Lounging
Starbucks said visitors to the coffee shops would be required to buy something in order to use the restroom or stay in the store, as the company’s new chief executive responded to a decline in sales.The New York Times - Jan. 16 -
FDA bans Red No. 3, artificial dye used in beverages, candy and other foods
The FDA said Wednesday it’s banning the use of Red No. 3, a synthetic dye that has been linked to behavioral problems in children and cancer in animals.NBC News - Jan. 15 -
FDA bans use of Red No. 3 dye in food, drinks
The U.S. Food and Drug Administration is moving to ban the use of Red No. 3 dye in food products.ABC News - Jan. 15 -
Trump Pentagon pick Hegseth nears US Senate approval after testy hearing
Former Fox News host claims ‘smear campaign’ sought to halt his nomination, but he appears likely to secure votesFinancial Times - Jan. 15 -
US LNG industry poised to expand as Trump vows to lift restrictions
S&P finds ramp-up of exports could add $1.3tn to American economy in next five years with capacity expected to doubleFinancial Times - Jan. 14 -
Approval of US leadership among NATO members sinks: Gallup
Approval of U.S. leadership across NATO member countries was lower in 2024 than during the first three years of President Biden’s term in office, according to a Gallup poll released Monday. In ...The Hill - Jan. 13 -
Trump’s trade coercion will harm the US and its allies
Greenland gambit suggests the country is now a threat to as much as a guarantor of securityFinancial Times - Jan. 13 -
Democratic states train non-doctors on providing abortions to expand US access
From Washington to Connecticut, pharmacists and healthcare workers pioneer efforts to limit abortion barriers. Democratic states across the country are embarking on a pioneering effort to ...The Guardian - Jan. 13 -
The King of Ozempic Is Scared as Hell
Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?Wired - Jan. 13 -
Barcelona uses its tourist tax to tackle the effects of climate change
Barcelona is one of the most visited cities in Europe. A small fee charged to visitors is helping the city address climate change.CBS News - Jan. 11 -
-
Constellation’s stock soared on AI hopes. Now the energy company is using those gains to buy Calpine in $16 billion deal.
Constellation Energy Corp., an electricity provider whose stock has doubled over the last year on hopes it will help meet the voracious energy demand created by artificial-intelligence ...MarketWatch - Jan. 10 -
Zuckerberg approved Meta’s use of ‘pirated’ books to train AI models, authors claim
Sarah Silverman and others file court case claiming CEO approved use of dataset despite warnings. Business live – latest updates Mark Zuckerberg approved Meta’s use of “pirated” versions of ...The Guardian - Jan. 10 -
Amazon aims to expand advertising business by letting retailers use its ad tools on their stores
Amazon Retail Ad Service will allow sites to show "contextually relevant ads in the right place and at the right time" in search results, the company said.CNBC - Jan. 9 -
Vay expands its teledriving car service in Las Vegas
Vay is launching is expanding its teledriving car service, an Uber-like service where your car is driven by someone in a remote location.VentureBeat - Jan. 8 -
Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact
At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss ...MarketWatch - Jan. 8 -
Sugary Drinks Linked to Global Rise in Diabetes, Heart Disease
A new study assesses the effects of sugar-laden beverages on global health, with higher rates of consumption found in Latin America and parts of Africa.The New York Times - Jan. 7 -
Sugary drinks linked to millions of new diabetes and heart disease cases – study
Tufts University analysis highlights rise in global health inequalities, with fastest growth in linked diseases in Africa. Sugary drinks are responsible for more than 2.2m new cases of diabetes and ...The Guardian - Jan. 6 -
US fines JetBlue $2m for ‘chronically delayed flights’ in unprecedented act
Department of Transportation denounces ‘unrealistic’ JetBlue schedules in yet another setback for the airline. The US Department of Transportation (DOT) announced on Friday a $2m fine against ...The Guardian - Jan. 3
